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Introduction
Capsule endoscopy (CE) is well-established for investigation of
small bowel bleeding [1], often presenting as iron deficiency
anemia (IDA) or melena [2, 3]. CE is usually performed non-
acutely as an outpatient procedure; however, there is now evi-
dence that performing CE closer to the index bleeding episode
increases its diagnostic yield (DY). Recent work suggests that in
small bowel bleeding, the maximum DY for CE is achieved
within the first 72 hours of presentation [4]. This is corrobora-
ted by studies showing that for the same indications, inpatient
CE has a higher DY compared to outpatient procedures [5–7].
However, there is overall scarce data on inpatient use of CE
(▶Table 1).
Although current practice varies, official guidelines general-
ly suggest performing CE in patients presenting acutely with
suspected small bowel bleeding after negative upper and lower
gastrointestinal endoscopy (i. e. negative bidirectional endos-
copy). However, performing colonoscopy in the acute setting
is a demanding task both for the patient and clinician, and is of-
ten limited by the quality of bowel preparation and patient fit-
ness or tolerance. At our large tertiary care hospital, there has
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ABSTRACT
Background and study aims Capsule endoscopy(CE) is a
well-established investigation for iron deficiency anemia
(IDA) and melena, usually following negative upper and
lower endoscopy. We aimed to study the effect of earlier
CE in the investigative pathway for inpatients with IDA or
melena at a large tertiary referral centre.
Patients and methods We analyzed inpatients undergo-
ing CE for IDA or melena from 2005 to 2017, without signs/
symptoms suggesting lower gastrointestinal tract patholo-
gy. Patients underwent CE following negative upper and
lower gastrointestinal endoscopy (Group 1), or negative up-
per gastrointestinal endoscopy (UGIE) only (Group 2).
Results One hundred and seventy inpatients underwent CE
for IDA (n=44) and melena (n=126). In Group 1, 46/95
(48.4%) patients had small bowel (SB) findings. CE found
16/95 (16.8%) gastric and 12/95 (12.6%) colon findings.
Three of 12 patients with colon findings required repeat co-
lonoscopy. One hundred and three colon investigations
were carried out for 95 admissions. In Group 2, 33/75
(44.0%) patients had SB findings. There were 12/75 (16.0%)
gastric and 11/75 (14.7%) colon findings. In patients with
positive CE, significant colonic findings led to colonoscopy
in 10 of 39 patients (diagnostic yield 6/10). Thirty-six pa-
tients had negative CE; 15 underwent colonoscopy (diag-
nostic yield 9/15). The remaining 21 of 36 patients with no
further colonoscopy did not develop adverse outcomes
related to colonic pathology. Twenty-six colon investiga-
tions were carried out in 75 admissions. Patients in Group 2
had shorter mean times from admission to CE (5.08±3.80
vs. 6.38±3.80 days; P=0.02) and hospital stays (10.5 ±9.58
vs. 12.5 ±11.4 days; P=0.04) compared to Group 1.
Conclusion Earlier use of CE in inpatients with melena or
IDA, no signs of lower gastrointestinal pathology and nega-
tive UGIE resulted in shortened hospital stays, significant DY
from both small bowel and upper gastrointestinal tract, and
two-thirds less unnecessary colon investigations without af-
fecting clinical outcomes.
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been a trend for performing CE following a negative index up-
per gastrointestinal endoscopy (UGIE), with anecdotal evidence
that by doing so, unnecessary colonoscopies have been avoided
in certain patients. Therefore, in this large retrospective study,
we aimed to examine the effect of earlier investigation with CE
for inpatients with suspected small bowel bleeding manifesting
as melaena or severe iron deficiency anaemia.
Patients and methods
This was a retrospective study of all inpatient CEs carried out at
our tertiary care academic center from March 2005 to March
2017, using a prospectively-designed and continuously main-
tained database. Data collected were:
▪ Patient demographics: age, gender
▪ Relevant past medical history: cardiovascular, liver and/or
renal disease; use of antiplatelet and/or anticoagulant med-
ications; any previous episodes of gastrointestinal bleeding;
▪ Circumstances of admission;
▪ CE indications and findings;
▪ Timing of CE relative to admission and prior conventional
endoscopies;
▪ Conventional endoscopies carried out within the past
6 months prior to admission;
▪ Further investigations and results;
▪ Patient outcomes, defining follow-up period as the date of
last recorded patient contact with local healthcare services,
discharge (back) to another health board, or death.
We analyzed inpatients undergoing CE for suspected small
bowel bleeding, defined as IDA or melena in patients with neg-
ative UGIE, with no other signs or symptoms suggesting lower
gastrointestinal tract pathology such as frank rectal bleeding,
diarrhea with associated significant weight loss or lower ab-
dominal pain. Over the study period, patients admitted with
UGIE-negative IDA or melena underwent CE either following
nondiagnostic bidirectional endoscopy (we called these pa-
tients Group 1) or following only negative UGIE (Group 2),
based on the senior clinician-in-charge’s individual investiga-
tive pathways.
CE was carried out with one of two commercially-available
CE systems, PillCam SB1/2 (Given Imaging Ltd, now Medtronic,
Minneapolis, Minnesota, United States) or Mirocam (Introme-
dic, Seoul, South Korea). Small bowel preparation was depen-
dent on timing of CE relative to UGIE or colonoscopy, as well as
the overall patient condition. In general, our center’s protocol
has been to use 2 L PEG, although an overnight fast alone was
sometimes used for frailer patients. If CE was carried out imme-
diately after colonoscopy, additional bowel preparation beyond
the 2 L PEG used for colonoscopy was not given. Simethicone
was administered with all CEs; use of prokinetics was guided
by evolving practice guidelines and individual patient need [8].
Over this time period, CEs were read and reported by one of
three experienced readers based at our center using the rele-
vant proprietary software. Speed and reading conditions varied
as per individual preference. Significant CE findings were those
deemed causative of the patient’s presentation. These includ-
ed: vascular lesions (e. g. angioectasias), areas of fresh and on-
going bleeding seen at the time of CE, inflammatory lesions (e.
g. ulcers, aphthae and strictures), various enteropathies such as
nonsteroidal anti-inflammatory drug-related enteropathy or
portal hypertensive enteropathy, and discrete bleeding mass
lesions. Over the study period, all CEs carried out at our center
have been recorded in a prospectively designed database with
the above details noted to be correct at time of CE.
Continuous data are reported as mean± standard deviation
(SD) or median (range) where appropriate. Statistical analyses
were carried out and normality of distributions was tested by
plotting histograms using the Analysis Toolpak in Microsoft Ex-
cel 2010 (Microsoft Corporation, Redmond, Washington, Uni-
ted States). For normally distributed data, Student’s t-test
(when n<30) or the Z-test (when n≥30) were used to compare
means, whereas the Mann-Whitney U-test was used for data
where a normal distribution could not be assumed. The Chi-
square test was used to compare proportions for discrete data
variables. A P value <0.05 was taken to denote statistical signif-
icance. No specific institutional ethical approval was required
for this study as the data used had been collected in the course
of routine patient care; ethical approval has been granted to
the unit as a whole for the safe, confidential collection and sto-
rage of relevant patient information relating to CE.
Results
Over the period from March 2005 to March 2017, 170 inpati-
ents underwent CE for suspected small bowel bleeding (104
male, 66 female; mean age 65.8±17.1 years). Forty-four pa-
tients had IDA and 126 had melena. Mean hemoglobin level
(Hb) at presentation was 82.8 ±22.4g/L. In total, there were 6
incomplete CEs; 2 were retained and required endoscopic or
surgical retrieval. Median follow-up time was 31.1 months
(range 0.03–121.4 months); however, it must be noted that
this was a continuously maintained database and follow-up
times depended on the time from CE to data collection for
each patient.
Patients were divided into two groups for analysis of out-
comes (▶Fig. 1). Group 1 comprised those with negative bidir-
ectional endoscopy, while Group 2 included those with only
negative UGIE. The groups had similar admission Hb, demo-
graphics, and medical history; they were also followed up for
similar periods of time overall (▶Table2). Patients in Group 2
were significantly more likely to have been admitted with mele-
na and were also significantly more symptomatic from blood
loss at the time of admission. Outcomes and further investiga-
tions carried out within the two groups are summarized in ▶Ta-
ble3.
CE findings and outcomes: Group 1
In Group 1, there were 95 CEs carried out following negative bi-
directional endoscopy. There were significant CE findings in 50
patients, i. e. DY 52.6%. Of these patients, 46 had SB findings;
17 of 46 patients had additional non-SB findings detected by
CE in the stomach (n =9), colon (n =6) or both (n=2). Another
4 patients had normal SB but colon findings seen on CE which
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were deemed relevant. Forty-five patients had nondiagnostic
CE following negative bidirectional endoscopy. In 31, the SB
was reported as normal whereas the other 14 had nonspecific
findings thought unlikely to be of clinical significance. The indi-
cation for CE was melena in 67 patients and IDA in 28. The pro-
portions of patients with melena and IDA with or without signif-
icant CE findings were not significantly different (▶Table3).
Therefore, in this group, CE found a total of 16 of 95 (16.8%)
gastric findings which had been missed on initial UGIE. Ten pa-
tients had repeat UGIE; in 9 of 10 the UGIE was done to further
investigate or manage lesions seen on CE while 1 was a “second
look.” There were missed colon findings in 12 of 95 (12.6%) pa-
tients, of whom three required repeat colonoscopy for APC; the
others were managed conservatively for confirmed or likely di-
verticular bleeds. A further three patients had repeat colonos-
copies due to rebleeding and/or ongoing bleeding, i. e. 6 of 95
patients had repeat colonoscopies. Two patients underwent
computed tomography (CT) colonography following CE. Dou-
ble balloon enteroscopy (DBE) was performed on seven pa-
tients in this group to manage SB lesions seen on CE. Seven pa-
tients required surgery to investigate discrete lesions seen on
CE (n =3) or to manage continued bleeding (n =4).
CE findings and outcomes: Group 2
In Group 2, 75 CEs were performed in patients who had nega-
tive UGIE only, with a DY of 39 of 75 (52.0%). In the 39 patients
with significant CE findings, 6 of 39 had normal SB but signifi-
cant non-SB findings in the stomach (n=2) and colon (n =4).
Of the 33 patients with SB findings on CE, 9 of 33 had additional
non-SB findings in the stomach (n=3), colon (n =2) or both (n =
4). Of the 36 patients with nondiagnostic CE, the SB was report-
ed as normal in 28. Three patients in this subgroup had addi-
tional non-SB findings (which were considered insignificant):
two in the stomach and one patient with findings in both stom-
ach and colon. The indication for CE was melena in 59 patients
and IDA in 16. Patients with nondiagnostic CE findings were sig-
nificantly more likely to have undergone CE for melaena rather
than IDA, compared to patients with significant CE findings (P =
0.03).
There were 12 of 75 (16.0%) gastric findings missed by initial
UGIE. Ten patients underwent repeat UGIE. Six UGIEs were
done to target lesions seen on CE (3 of these were push enter-
oscopies to reach the duodenum). Eleven of 75 (14.7%) pa-
tients had new colon findings; all these findings were AVMs
and/or colonic bleeding. Overall in this group, 25 patients un-
derwent colonoscopy following CE. Seven colonoscopies were
done to target lesions seen on CE while the remainder were car-
ried out in patients experiencing continued bleeding or symp-
toms. Fourteen of 25 colonoscopies found likely causes for the
patients’ presentations; notably, one patient was found to have
a colon adenocarcinoma. In the patients with negative colonos-
copies, most were managed conservatively with spontaneous
resolution of bleeding in six; in two patients repeat UGIE found
the likely sources of blood loss. One patient had CT colonogra-
phy following normal CE with no cause found.
Nine patients underwent DBE to further investigate discrete
lesions seen on CE (n =3), manage SB angioectasias (n =3) and
further investigate/manage an area of active SB bleeding seen
on CE (n =3). Four patients had surgery for lesions seen on CE.
Comparison of colon investigations per episode of
gastrointestinal bleeding between the two groups
In Group 1, a total of 103 colon investigations (colonoscopies
and CT colonographies) were performed for 95 inpatient epi-
sodes of suspected small bowel bleeding, giving a rate of 1.08
colon investigations per episode. The overall diagnostic yield of
▶ Table 1 Summary of previous studies on inpatient use of CE.
Authors, Year Type of study CE procedure Patients Findings
Robinson et al.,
2011 [5]
Retrospective,
multicenter
PillCam SB2, PEG,
no simethicone,
prokinetics as
indicated
Inpatients: 167
Outpatients: 540
Significant findings, endoscopic placement, nongastric
passage and incomplete CE more likely in inpatients.
Inpatients had longer GTT, were more likely to be male
and have overt bleeding.
Lepileur et al.,
2012 [6]
Retrospective,
multicenter
PillCam M2A,
PEG
Inpatients: 137
Outpatients: 774
Predictive factors for positive CE: males, > 60 years,
overt bleeding, inpatients
Yazici et al.,
2012 [7]
Retrospective,
single center
PillCam SB, no
laxative prepa-
ration
Inpatients: 70
Outpatients: 264
Inpatients were older, more likely to have overt bleed-
ing, and active bleeding was more commonly found in
inpatients.
CE completion rate significantly lower in inpatients and
patients with gastrointestinal bleeding; prolonged GTT
and SBTT in inpatients.
Results amplified when looking only at ICU inpatients
vs. general ward patients.
Singh et al.,
2013 [4]
Retrospective,
single center
PillCam SB/SB2,
no laxative prep-
aration
Inpatients: 144
Outpatients: 116
(all patients having CE
for overt OGIB)
Early use of CE within 3 days of admission associated
with higher diagnostic yield, therapeutic intervention
rate and reduced length of stay.
CE capsule endoscopy; GTT gastric transit time; ICU intensive care unit; OGIB obscure gastrointestinal bleeding; SBTT small bowel transit time; NS not specified
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these colon investigations was 3.9%. Using the alternative ap-
proach in Group 2, 26 colon investigations were performed for
75 inpatient episodes of suspected small bowel bleeding, i. e.
0.35 colon investigations were carried out per episode. The di-
agnostic yield in this group was 53.8%.
Length of time between admission and CE
Examining only data from patients admitted for gastrointesti-
nal bleeding (excluding elective admissions and patients with
unrelated initial presentations who developed gastrointestinal
bleeding during their hospital stay), patients in Group 2, under-
going CE following negative UGIE only, had significantly shorter
mean times from admission to CE compared to patients in
Group 1 (5.08±3.80 vs. 6.38±3.80 days; P=0.02) and shorter
overall admission length (10.5±9.58 vs. 12.5 ±11.4 days; P=
0.04). This was despite patients in Group 2 being more sympto-
matic of blood loss at the time of admission, including a greater
proportion of patients displaying hemodynamic compromise
when admitted (14/75 patients in Group 2 vs. 4/95 patients in
Group 1; P=0.002).
Discussion
In this study, we found that the earlier use of CE for inpatients
with melena or IDA following negative UGIE reduces the need
for subsequent colonoscopy and shortens admission times.
Previous data from Singh et al. [4] in a group of 144 inpatients
showed that earlier use of CE (within 3 days of admission) was
March 2005 – March 2017: 2019 CEs; 264 (13.1 %) inpatients
170 inpatients with IDA and melaena
All patients: initial – ve UGIE (n = 170)
CE referral
– ve colonoscopy (n = 95) No colonoscopy (n = 75)
Group 1
CE following – ve bidirectional endoscopy
57M/38F; mean age 66.7 ± 14.6 yrs
Group 2
CE following – ve UGIE only
48M/27F; mean age 64.7 ± 19.8 yrs
Total burden of colon Ix:
103 colon Ix in 95 episodes of IDA/melaena
Ix per episode: 1.08
diagnostic yield: 3.9 % (4/103)
Total burden of colon Ix:
26 colon Ix in 75 episodes of IDA/melaena
Ix per episode: 0.35
diagnostic yield: 53.8 % (14/26)
– ve CE (n = 45)
insignificant findings: 5 
(gastric)
+ ve CE (n = 39)
gastric findings: 9
colon findings: 10
small bowel findings: 33
+ ve CE (n = 50)
gastric findings: 11
colon findings: 12
small bowel findings: 46
– ve CE (n = 36)
insignificant findings: 3 
gastric, 1 colon
Rpt UGIE: 4 Rpt UGIE: 9Rpt UGIE: 6 Rpt UGIE: 1
Colon Ix
colonoscopy: 45
rpt colonoscopy: 2
CT colon: 1
Colon Ix
colonoscopy: 10
CT colon: 0
Colon Ix
colonoscopy: 50
rpt colonoscopy: 4
CT colon: 1
Colon Ix (ongoing 
bleeding)
colonoscopy: 15
CT colon: 1
▶ Fig. 1 Flow diagram showing investigative pathways in our group of inpatients with IDA/melena. + ve positive; -ve negative; Ix investigations;
rpt repeat.
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associated with higher DY, rates of therapeutic intervention
and decreased length of stay. Similarly, our patients who under-
went CE earlier in the diagnostic pathway also had a significant-
ly shorter mean length of stay by about 2 days (P=0.04). This
translates to potentially significant cost savings or at least in-
creased patient turnover and therefore capacity, especially im-
portant in large hospitals with high patient caseload. In a 2006
study by Marmo et al. [9], soon after the introduction of com-
mercial CE, patients undergoing CE for obscure gastrointestinal
bleeding (OGIB) required a mean of 1.7 hospital admissions to
reach a positive diagnosis, with a mean of 15.5 days of hospital
stay; 42% had more than one colonoscopy; 44.6% had two or
more UGIEs. Hospital admissions were the biggest cause of re-
source utilization in their group of patients, followed closely by
colonoscopies and UGIEs. We do, however, acknowledge that
cost savings would vary between countries and healthcare sys-
tems as the cost of CE may not be adequately reimbursed at
some centers.
From our experience, the reasons for the shortened length
of stay in patients in Group 2 could be related to the additional
time required to perform both upper and lower gastrointestinal
endoscopies before making the decision to proceed to CE.
Therefore, early use of inpatient CE was useful in guiding the
choice of the next most appropriate route of investigation or
management, as well as aiding the decision whether to proceed
with these investigations and interventions urgently or follow-
ing discharge. Similarly, in previous studies where CE was used
acutely or semi-acutely to investigate gastrointestinal bleeding
(▶Table 4), CE findings showed good correlation with subse-
quent UGIE where CE was performed as a first-line investigation
before any other endoscopies [10–14]; CE carried out after
endoscopic imaging was effective in directing the subsequent
route of investigation [15–21].
These findings are corroborated by our study. Patients in
Group 1 underwent 3.13 as many colon investigations per ad-
mission for IDA or OGIB compared to those in Group 2; how-
▶ Table 2 Comparison of patient characteristics between patients undergoing CE following negative bidirectional endoscopy and patients undergo-
ing CE following negative UGIE only.
Group 1: CE after negative
bidirectional endoscopy
Group 2: CE after negative
UGIE only
P value
Total number 95 75
M/F (%) 57M (60%)/ 38F (40%) 48M (64%)/ 27F (36%) 0.59
Age; years (mean± SD) 66.7 ± 14.6 64.7 ± 19.8 0.46
PMH
Liver disease (%) 15 (15.8) 11 (14.7) 0.84
Cardiovascular disease (%) 46 (48.4) 29 (38.7) 0.20
On anticoagulants/ antiplatelets (%) 37 (38.9)
24 on anticoagulants
17 on antiplatelets
23 (30.7)
10 on anticoagulants
13 on antiplatelets
0.26
Renal disease (%) 10 (10.5) 9 (12.0) 0.76
Previous episode/s of gastrointestinal bleeding (%) 28 (29.5) 24 (32.0) 0.72
Admission details
Melena (%) 48 (50.5) 50 (66.7) 0.03
IDA only (%) 28 (30.4) 16 (21.3) 0.23
Other (%) 19 (20.0) 9 (12.0) 0.16
Symptomatic from blood loss (%) 31 (32.6) 38 (50.7) 0.02
Hemodynamic compromise at time of admission (%)
(collapse, hypotension, tachycardia)
4 (4.2) 14 (18.7) 0.002
Admission Hb; g/L (mean± SD) 82.8 ± 20.7 82.9 ± 24.6 0.98
Length of time from admission to CE; days (mean ± SD)1 6.38 ± 3.80 (n =68) 5.08 ± 3.80 (n =66) 0.02
Total length of admission; days (mean ± SD)1 12.5 ± 11.4 (n =68) 10.5 ± 9.58 (n =66) 0.04
Follow-up time after CE2; months (mean ± SD) 37.9 ± 31.5 35.8 ± 31.9 0.62
CE capsule endoscopy; Hb hemoglobin; IDA iron deficiency anemia; PMH past medical history; SD standard deviation
1 These calculations include only data from patients admitted specifically for IDA/melena; i. e. excluding patients admitted electively or with unrelated initial pre-
sentations.
2 Follow-up as recorded in electronic hospital records– i. e. until time of last recorded patient contact, discharge (back) to another health board, or death.
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ever, in Group 2, use of CE earlier in the diagnostic pathway in-
creased the DY of the resulting colonoscopies. Moreover, no ad-
verse outcomes related to colon pathology were reported in
those patients who did not have colon investigations following
CE. Notably, our study reports a higher completion rate with six
incomplete CEs and only two retained capsules in 170 inpatient
CEs, compared to previously quoted inpatient completion rates
of 50% by Dunnigan et al. [22] and 68.6% from Yazici et al. [7].
This therefore implies that in selected patients with IDA or me-
lena, without frank rectal bleeding or other such signs or symp-
toms suggesting lower gastrointestinal tract pathology, CE
could be used as a diagnostic or screening tool following initial
UGIE. The results of CE were able to assist clinicians in deter-
mining the next most appropriate investigation, with no missed
diagnoses in our group of patients.
The advantages of such an approach are appealing as a sig-
nificant proportion of patients with gastrointestinal bleeding or
suspected gastrointestinal bleeding have been shown to re-
quire multiple investigations. Woodward et al. conducted an a-
nalysis on the length of endoscopic workup in a large group of
451,470 patients presenting with gastrointestinal bleeding
[23]. A quarter of these patients required more than one proce-
dure to investigate and/or manage gastrointestinal bleeding,
with an average of 2.4 procedures per patient. In particular, pa-
tients with anemia were the least likely to be managed with a
single procedure, with 20% and 21% of these patients requiring
further UGIEs and colonoscopies, respectively. Similarly, in a
2015 study, Sonnenberg modelled test sequences in patients
with gastrointestinal bleeding, and found an average of 2.7
procedures performed per patient, with a significant 5% of pa-
tients requiring more than six procedures [24].
An alternative approach to CE is for patients with ongoing
gastrointestinal bleeding to undergo repeat UGIE and colonos-
copy; this would be supported by the incidence of “missed” up-
per and lower gastrointestinal findings seen in our group. This
approach is in line with work by Fry et al. [25], but on the other
hand, is not suggested by the current guidelines, and would be
limited by increased investigative burden and poor patient ac-
ceptability. Furthermore, the current convention of performing
colonoscopy before CE is based on older, possibly now less-sup-
ported data that suggest the small bowel is the bleeding source
in 10% of gastrointestinal bleeding [26]. With the technological
advances now available, we would suggest that the increasing
accessibility of CE as a diagnostic test is combined with com-
▶ Table 3 Investigations and management in our group of inpatients with IDA/melena.
Group 1:
CE following -ve bidirectional endoscopy
Group 2:
CE following -ve UGIE only
CE findings +ve CE – ve CE +ve CE – ve CE
Number of patients (%) 50 (52.6) 45 (47.4) 39 (52.0) 36 (48.0)
Incomplete CEs (%) 3 (3.2) 3 (4.0)
UGIE and colonoscopy
Missed findings on initial UGIE (%) 11 (22.0) 5 (11.1)
all insignificant
9 (23.1) 3 (8.3)
all insignificant
Missed findings on initial colonoscopy
(Group 1) (%)
12 (24.0) – NA
Colon findings on CE (Group 2) (%) NA 10 (25.6) 1 (2.8)
insignificant
Repeat UGIEs (%) 6 (12.0) 4 (8.9) 9 (23.1) 1 (2.8)
Total number of colon procedures/Ix
carried out
Initial colonoscopy: 50
Repeat colonoscopy: 4
CT colon: 1
Total: 55
Initial colonoscopy: 45
Repeat colonoscopy: 2
CT colon: 1
Total: 48
Initial colonoscopy: NA
Colonoscopy: 10
CT colon: 0
Total: 10
Initial colonoscopy: NA
Colonoscopy: 15
CT colon: 1
Total: 16
Total burden of colon Ix 103 colon Ix for 95 episodes 26 colon Ix for 75 episodes
Diagnostic yield of colon Ix 3.9% (4/103) 53.8% (14/26)
Other Ix and/or management following CE
DBE (%) 7 (14.0) – 9 (23.1) –
CT angiography (%) 5 (10.0) 3 (6.7) 1 (2.6) 2 (5.6)
Repeat CE (%) – – 2 (5.1) –
Surgery (%) 5 (10.0) 2 (4.4) 4 (10.3) –
– ve negative; + ve positive; CE capsule endoscopy; DBE double balloon enterography; Ix investigations; SD standard deviation; UGIE upper gastrointestinal endos-
copy
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prehensive clinical assessment to ensure an appropriate and
timely choice of investigation for patients with gastrointestinal
bleeding.
Limitations of this study stem largely from its retrospective
design including missing data, dependence on good prior re-
cordkeeping and the possible effects of advances in CE technol-
ogy since its introduction to clinical practice. However, al-
though image quality may have improved over the study peri-
od, the main finding of concern in patients with gastrointestinal
bleeding is localization of blood within the gastrointestinal
tract rather than detailed lesion definition; this is an obvious
finding where technological improvement may not have had as
great an impact. Furthermore, our center’s data date from
2005, when CE had already been approved for conventional
clinical use, with acceptable image quality from the first models
which we had used. Similarly, our center had started using PEG
for bowel preparation at an early stage, almost from the begin-
ning of the capsule service, even though official guidelines had
not been standardized then; most of the patients in our group
received similar bowel preparation throughout the study peri-
od.
Another limitation stemming from the retrospective study
design is that choice of investigative pathway and CE timing in
our patients was determined by consultant preference. Despite
this, the demographics and admission data suggest that the
two groups were comparable. Given that melena was more of-
ten the indication for CE in Group 2, our results would also sug-
gest that such patients with melena and negative UGIE are
more likely to benefit from earlier use of CE. Although this ap-
proach seems logical, in routine clinical practice, most centers
currently reserve use of CE until a negative colonoscopy has oc-
curred. Furthermore, and despite the recognized disadvanta-
ges of a retrospective study, such a study has the benefit of a
large patient group, longer follow-up times and accurate re-
flection of “real world” experience.
Conclusion
In conclusion, inpatient CE for IDA or melena had a diagnostic
yield of 52.3% at our center. In such patients, use of CE earlier
in the investigative pathway significantly reduced the number
of colonic investigations performed without compromising
clinical outcomes. This has the potential to improve the patient
experience by reducing the number of negative invasive proce-
dures. We found that earlier use of CE also shortened hospital
stays. Our findings inspire confidence in earlier use of CE in in-
patients with IDA or melena in the absence of signs and symp-
toms suggestive of colonic pathology.
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